Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
Bob Mulroy
Advertisement
Bob Mulroy is director and chief executive officer of Partner Therapeutics
Articles by Bob Mulroy
Advertisement
Latest Updated Articles
Partnering to Respond to a Possible Nuclear ThreatMay 25th 2022
Advertisement
Advertisement
Trending on PharmExec
1
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
2
The Economics of the 340B Drug Pricing Program: Strategic Imperatives for the Life Sciences Industry in 2026
3
Eli Lilly and Abbisko Announce Drug Development Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration
5